Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck.
暂无分享,去创建一个
R. Hitt | J. García-Saenz | H. Cortés-Funes | A. Irigoyen | J. Grau | J. Cruz-Hernández | J. Cruz-Hernandez